Reckitt Benckiser Group (OTCMKTS:RBGLY) Reaches New 12-Month Low at $10.24

Reckitt Benckiser Group plc (OTCMKTS:RBGLY)’s stock price hit a new 52-week low on Wednesday . The company traded as low as $10.24 and last traded at $10.29, with a volume of 1310476 shares trading hands. The stock had previously closed at $10.34.

Wall Street Analyst Weigh In

Separately, BNP Paribas upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research report on Tuesday, January 9th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Reckitt Benckiser Group has an average rating of “Hold” and an average price target of $6,978.00.

Reckitt Benckiser Group Stock Down 0.1 %

The firm’s 50 day moving average is $12.38 and its two-hundred day moving average is $13.38.

Reckitt Benckiser Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Monday, June 3rd. Shareholders of record on Friday, April 12th will be issued a dividend of $0.2701 per share. This is an increase from Reckitt Benckiser Group’s previous dividend of $0.18. The ex-dividend date is Thursday, April 11th.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.